Increased exercise ejection fraction and reversed remodeling after long-term treatment with metoprolol in congestive heart failure: a randomized, stratified, double-blind, placebo-controlled trial in mild to moderate heart failure due to ischemic or idiop-Reference-Cited by-同舟云学术

Increased exercise ejection fraction and reversed remodeling after long-term treatment with metoprolol in congestive heart failure: a randomized, stratified, double-blind, placebo-controlled trial in mild to moderate heart failure due to ischemic or idiop

Published:2003-10 Issue:5 Volume:5 Page:679-691
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European Journal of Heart Failure

Author:

Waagstein F.¹,Strömblad O.¹,Andersson B.¹,Böhm M.²,Darius M.³,Delius W.⁴,Goss F.⁵,Osterziel K.J.⁶,Sigmund M.⁷,Trenkwalder S.-P.⁸,Wahlqvist I.⁹

Affiliation:

1. Wallenberg Laboratory and Department of Cardiology; Sahlgrenska University Hospital; Göteborg SE-413 45 Sweden

2. Klinik und Poliklinik für Innere Medizin III; Universität des Saarlandes; Homburg/Saar Germany

3. Department of Medicine II; Johannes Gutenberg-University; Mainz Germany

4. Städt Krankenhaus München-Bogenhausen, I Med. Abteilg/Kardiol Ambulanz; Munich Germany

5. Private Cardiologist Marienplatz 1; Munich Germany

6. Charité Campus Berlin-Buch Franz Volhard Klinik Humboldt University; Berlin Germany

7. Department of Cardiology; Dr-Horst-Schmidt-Kliniken GmbH; Wiesbaden Germany

8. Department of Medicine; University of Munich, Starnberg Hospital; Germany

9. R&D AstraZeneca; Mölndahl Sweden

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Reference43 articles.

1. Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction;Sharpe;Lancet,1988

2. For the SAVE Investigators. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effect of captopril;Sutton;Circulation,1994

3. The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomized trial;CIBIS-II Investigators and Committees;Lancet,1999

4. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF);MERIT-HF Study Group;Lancet,1999

5. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study;Packer;Circulation,2002

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integration of implantable device therapy in patients with heart failure. A clinical consensus statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC);European Journal of Heart Failure;2024-01-25

2. Mitral Interventions in Heart Failure;JACC: Heart Failure;2023-08

3. Improve heart function to improve heart failure outcomes: the d isease‐modifying effects of spironolactone;European Journal of Heart Failure;2023-01

4. Secondary Mitral Regurgitation: Cardiac Remodeling, Diagnosis, and Management;Structural Heart;2022-12

5. The Impact of Cardiac Comorbidity Sequence at Baseline and Mortality Risk in Type 2 Diabetes Mellitus: A Retrospective Population-Based Cohort Study;Life;2022-11-22